A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants
Condition: Diarrhoea Interventions: Drug: altSonflex Placebo; Biological: altSonflex1-2-3 Dose C; Biological: altSonflex1-2-3 Dose B; Biological: altSonflex1-2-3 Dose A; Biological: GSK's Meningococcal A, C, Y and W-135 conjugate vaccine; Combination Product: GSK's Tetanus toxoid, reduced diphtheria toxoi d and acellular pertussis vaccine; Combination Product: GSK's Poliomyelitis, diphtheria, tetanus and pertussis vaccine; Combination Product: Sanofi Pasteur's Typhoid Vi polysaccharide vaccine; Biological: Serum Institute of India's Measles and rubella vaccine Sponsor: GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Children | Diarrhoea | Diphtheria | India Health | Measles | Measles Vaccine | Men | Meningitis | Meningitis Vaccine | Polio | Polio Vaccine | Research | Rubella | Rubella Vaccine | Study | Tetanus | Tetanus Diptheria Pertussis Vaccine Tdap,Dtap,Dpt | Tetanus Vaccine | Typhoid | Typhoid Vaccine | Vaccines | Whooping Cough (Pertussis) Vaccine